维普中文期刊产品整合服务
46篇 您的检索式:作者名="Schepke M"
    题名 作者 年代 出处 被引量
1Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension显示文摘Heller J Schepke M Neef M 2002Hepatol2002,37,6:1
2Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study显示文摘Schepke M Appenrodt B Heller J 2006Liver lnt2006,26,:1
3Prognostic factors for pa-tients with cirrhosis and kidney dysfunction in the era of MELD:results of a prospective study显示文摘Schepke M Appenrodt B Heller J 2006Liver Int2006,26,:1
4Increased uroten?sin II plasma levels in patients with cirrhosis and portal hyper?tension显示文摘HELLERJ SCHEPKE M NEFF M 2002J Hepatol2002,37,6:1
5MRI in cavernous transformation of the portal vein: secondary biliary abnormalities and portoportal collaterals显示文摘Schaible R Textor J Schepke M 2002Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr2002,174,4:1
6Altered adrenergic re- sponsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis 显示文摘Heller J Schepke M Gehnen N 1999Gastroenterology1999,116,2:1
7Increased urotensin Ⅱ plasma levels in patients with cirrhosis and portal hypertension显示文摘Heler J Schepke M Neef M 2002J Hepatol2002,37,6:1
8MRI in cavernous trans formation of the portal vein:secondary biliary abnormalities and portoportal collaterals显示文摘Schaible R Textorv J Schepke M 2002Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr2002,174,11:1
9Neutropenic enterocolitis in adults: systematic analysis of evidence quality显示文摘Gorschluter M Mey U Strehl J Ziske C Schepke M Ingo GH 2005Eur J Haematol2005,75,1:1
10MRI in cavernous transformation of the portal vein:secondary biliary abnormalities and portoportal collaterals显示文摘Schaible R Textor J Schepke M Wolff M Schild H Kreft B 2002Rofo2002,174,11:1
11Increased wrotensin Ⅱ plasma levels in patients with cirrhosis and portal hypertension 显示文摘Heller J Schepke M Neef M 2002J Hepatol2002,37,6:1
12Increased urotensin Ⅱ plasma levels in subjects with cirrhosis and portal hypertension 显示文摘Heller J Schepke M Neef M 2002J Hepatol2002,37,6:1
13Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding显示文摘Schepke M 2009Dtsch Med Wochenschr2009,134,37:1
14Irbesartan plus lowdose propranolol versus lowdose propranolol alone in cirrhosis:aplacebocontrolled, double-bli nd study显示文摘Schepke M Wiest R Flacke S 2008Am J Gastroenterol2008,103,5:1
15Ligation versus propranolol for theprimary prophylaxis of variceal bleeding in cirrhosiS显示文摘 Kleber G Nurnberg D 2004Hepatology2004,40,1:1
16Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD : results of a prospective study 显示文摘Schepke M Appenrodt B Heller J 2006Liver International2006,26,7:1
17Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for the prevention of varlceal rebleeding in cirrhotic patients: a randomized controlled triM显示文摘G tl lberg V Schepke M Geigenberger G 2002Scandinavian Journal of Gastroenterology2002,37,3:1
18Tran-sjugular intrahepatic portosystemic shunting is not superior toendoscopic variceal band ligation for prevention of variceal re-bleeding in cirrhotic patients: a randomized, controlled trial显示文摘GULBERG V SCHEPKE M GEIGENBERGER G etal 2002Scand J Gastroenterol2002,37,3:1
19Comparison of MELD,Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting 显示文摘Schepke M Roth F Fimmers R 2003Am J Gastroenterology2003,98,5:1
20Hormonal responses to the new potent GnRH antagonist Cetrorelix显示文摘Klingmuller D Schepke M Enzweiler C 1993Acta Endocrinol(Copenh)1993,128,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费